JP2015525349A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525349A5 JP2015525349A5 JP2015516637A JP2015516637A JP2015525349A5 JP 2015525349 A5 JP2015525349 A5 JP 2015525349A5 JP 2015516637 A JP2015516637 A JP 2015516637A JP 2015516637 A JP2015516637 A JP 2015516637A JP 2015525349 A5 JP2015525349 A5 JP 2015525349A5
- Authority
- JP
- Japan
- Prior art keywords
- stained cells
- stained
- cells
- tumor
- density
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 18
- 238000000034 method Methods 0.000 claims 16
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 5
- 102100030385 Granzyme B Human genes 0.000 claims 5
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 5
- 101001009603 Homo sapiens Granzyme B Proteins 0.000 claims 5
- 210000002865 immune cell Anatomy 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 238000012744 immunostaining Methods 0.000 claims 2
- 230000008595 infiltration Effects 0.000 claims 2
- 238000001764 infiltration Methods 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 230000008520 organization Effects 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IBPCT/IB2012/001446 | 2012-06-14 | ||
| IB2012001446 | 2012-06-14 | ||
| PCT/EP2013/062405 WO2013186374A1 (en) | 2012-06-14 | 2013-06-14 | Method for quantifying immune cells in tumoral tissues and its applications |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015525349A JP2015525349A (ja) | 2015-09-03 |
| JP2015525349A5 true JP2015525349A5 (enExample) | 2016-07-14 |
| JP6449765B2 JP6449765B2 (ja) | 2019-01-09 |
Family
ID=46881097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516637A Active JP6449765B2 (ja) | 2012-06-14 | 2013-06-14 | 腫瘍組織における免疫細胞を定量するための方法及びその応用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10317408B2 (enExample) |
| EP (1) | EP2861986B1 (enExample) |
| JP (1) | JP6449765B2 (enExample) |
| KR (1) | KR102179848B1 (enExample) |
| CN (1) | CN104541167B (enExample) |
| AU (1) | AU2013276470B2 (enExample) |
| BR (1) | BR112014031143B8 (enExample) |
| CA (1) | CA2873278C (enExample) |
| DE (1) | DE13731071T1 (enExample) |
| ES (1) | ES2902879T3 (enExample) |
| IL (1) | IL235738B (enExample) |
| SG (1) | SG11201408107RA (enExample) |
| WO (1) | WO2013186374A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2701092T5 (es) | 2014-02-24 | 2022-05-12 | Ventana Med Syst Inc | Procedimientos, kits y sistemas para puntuar la respuesta inmunitaria al cáncer por detección simultánea de CD3, CD8, CD20 y FOXP3 |
| EP3195191B1 (en) * | 2014-09-03 | 2020-10-21 | Ventana Medical Systems, Inc. | Systems and methods for calculating immune scores |
| CN107109459A (zh) * | 2014-11-05 | 2017-08-29 | 加利福尼亚大学董事会 | 用于分层对阻断pd1/pdl1轴的疗法的无响应者的方法 |
| CA2973878A1 (en) | 2015-01-22 | 2016-07-28 | University Of Massachusetts | Cancer immunotherapy |
| CN113671186A (zh) * | 2015-10-23 | 2021-11-19 | 诺华股份有限公司 | 对包含肿瘤组织的样品评分的方法 |
| MX393482B (es) * | 2016-05-09 | 2025-03-24 | Inst Nat Sante Rech Med | Metodos para clasificar pacientes con un cancer solido |
| US11315240B2 (en) * | 2016-05-18 | 2022-04-26 | Hoffmann-La Roche Inc. | System and method of tumor classification |
| WO2018027223A1 (en) * | 2016-08-05 | 2018-02-08 | Duke University | Camkk2 inhibitor compositions and methods of using the same |
| EP3532984B1 (en) * | 2016-10-27 | 2024-05-08 | Koninklijke Philips N.V. | Apparatus for determining cellular composition information in one or more tissue samples |
| WO2018081817A2 (en) | 2016-10-31 | 2018-05-03 | University Of Massachusetts | Targeting microrna-101-3p in cancer therapy |
| CN106846310A (zh) * | 2017-01-19 | 2017-06-13 | 宁波江丰生物信息技术有限公司 | 一种基于免疫组化技术的病理辅助分析方法 |
| EP3659110A1 (en) * | 2017-07-24 | 2020-06-03 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in tumor samples |
| US11814623B2 (en) | 2018-01-30 | 2023-11-14 | University Of Massachusetts | Methods of treating a wound using epigenetic regulation |
| WO2019149817A1 (en) | 2018-01-31 | 2019-08-08 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in stage iii colorectal cancer |
| EP3921648A1 (en) * | 2019-02-05 | 2021-12-15 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer |
| US20220236276A1 (en) | 2019-06-03 | 2022-07-28 | Inserm (Institut National De La Santé Et De La Recherch Médicale | Methods for modulating a treatment regimen |
| AU2020378280A1 (en) | 2019-11-07 | 2022-04-07 | Feng Biosciences, Ltd. | Classification of tumor microenvironments |
| CN111551546B (zh) * | 2020-06-01 | 2023-01-03 | 南京瑟斯检测科技有限公司 | 一种基于光学微腔结构超材料的免疫组化便捷检测方法 |
| EP4172628A1 (en) * | 2020-06-30 | 2023-05-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapy and radical surgery |
| CN115997123A (zh) | 2020-06-30 | 2023-04-21 | 国家医疗保健研究所 | 用于预测实体癌患者在术前辅助治疗后复发和/或死亡风险的方法 |
| TWI838687B (zh) * | 2021-01-30 | 2024-04-11 | 奇美醫療財團法人奇美醫院 | 評估腫瘤標本免疫狀態的方法 |
| CN113092202A (zh) * | 2021-03-25 | 2021-07-09 | 上海福君基因生物科技有限公司 | 一种胃癌预后预测装置 |
| CN113515077A (zh) * | 2021-04-23 | 2021-10-19 | 重庆德方信息技术有限公司 | 人体细胞染色过程监控系统及方法 |
| WO2023018085A1 (ko) * | 2021-08-10 | 2023-02-16 | 주식회사 루닛 | 병리 슬라이드 이미지와 관련된 정보를 출력하는 방법 및 장치 |
| US20250035635A1 (en) | 2022-03-17 | 2025-01-30 | Institut National De La Sante Et De La Recherche Medicale | Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer |
| US12173081B2 (en) | 2023-03-21 | 2024-12-24 | Biograph 55, Inc. | CD19/CD38 multispecific antibodies |
| CN116646088B (zh) * | 2023-07-27 | 2023-12-01 | 广东省人民医院 | 一种预测方法、装置、设备及介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000501184A (ja) * | 1995-11-30 | 2000-02-02 | クロマビジョン メディカル システムズ，インコーポレイテッド | 生体標本の自動画像分析の方法および装置 |
| EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| EP1969338B1 (en) * | 2005-12-19 | 2016-08-24 | Ventana Medical Systems, Inc. | Automated label printing for tissue specimen slides |
| CA2737116C (en) * | 2008-09-16 | 2019-01-15 | Historx, Inc. | Reproducible quantification of biomarker expression |
| FR2964744B1 (fr) * | 2010-09-10 | 2015-04-03 | Univ Versailles St Quentin En Yvelines | Test pronostic de l'evolution d'une tumeur solide par analyse d'images |
-
2013
- 2013-06-14 EP EP13731071.0A patent/EP2861986B1/en active Active
- 2013-06-14 US US14/407,698 patent/US10317408B2/en active Active
- 2013-06-14 KR KR1020157000987A patent/KR102179848B1/ko active Active
- 2013-06-14 JP JP2015516637A patent/JP6449765B2/ja active Active
- 2013-06-14 BR BR112014031143A patent/BR112014031143B8/pt active IP Right Grant
- 2013-06-14 AU AU2013276470A patent/AU2013276470B2/en not_active Ceased
- 2013-06-14 DE DE13731071.0T patent/DE13731071T1/de active Pending
- 2013-06-14 SG SG11201408107RA patent/SG11201408107RA/en unknown
- 2013-06-14 WO PCT/EP2013/062405 patent/WO2013186374A1/en not_active Ceased
- 2013-06-14 CN CN201380030888.7A patent/CN104541167B/zh active Active
- 2013-06-14 ES ES13731071T patent/ES2902879T3/es active Active
- 2013-06-14 CA CA2873278A patent/CA2873278C/en active Active
-
2014
- 2014-11-17 IL IL235738A patent/IL235738B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015525349A5 (enExample) | ||
| DE13731071T1 (de) | Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen | |
| KR102770415B1 (ko) | 항-pd-1/pd-l1에 의해 치료되는 암 환자의 종양-림프구 침윤 및 결과를 모니터링하기 위한 라디오믹스 기반 영상 툴 | |
| Kidman et al. | Characteristics of TCR repertoire associated with successful immune checkpoint therapy responses | |
| Li et al. | CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma | |
| Senter-Zapata et al. | The role of micro-CT in 3D histology imaging | |
| Ryu et al. | Impact of 18F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study | |
| Kozlowski et al. | An entirely automated method to score DSS-induced colitis in mice by digital image analysis of pathology slides | |
| WO2016145366A8 (en) | Systems and methods for serial staining and imaging | |
| Ehrig et al. | Comparison of crack detection methods for analyzing damage processes in concrete with computed tomography | |
| Di Gangi et al. | Analytical metabolomics-based approaches to pancreatic cancer | |
| WO2014127267A9 (en) | Methods and tools for the diagnosis and prognosis of urogenital cancers | |
| Bae et al. | Optimal interval for repeated gastric cancer screening in normal-risk healthy Korean adults: a retrospective cohort study | |
| US10036751B2 (en) | Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment | |
| CN103217367A (zh) | 基于三维随机球仿真的雪粒径谱分布特征参数优化方法 | |
| Jasar et al. | Clinicopathological and histomorphological association in K-ras mutated colorectal cancer | |
| Yao et al. | Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases | |
| Kivelä | Composition and prognostic significance of T helper lymphocytes in lung cancer | |
| Kimura et al. | 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts the Function of Tumor Immune Microenvironment in Early Triple-Negative Breast Cancer | |
| Sennerstam | Mammography screening initially yields large tumors and several years later an increase in small tumors–transient medium sized tumors appeared | |
| Banzo et al. | Resistance to First Line Chemotherapy Treatment in a Patient Diagnosed with Nodular Lymphocyte-predominant Hodgkin Lymphoma Identified by 18F-FDG PET/CT: Diagnostic and Therapeutic Implications | |
| Baptista et al. | 34th European Congress of Pathology-Abstracts | |
| JP2025537743A (ja) | がん免疫療法の有効性を予測するための新規バイオマーカー | |
| Chinnam et al. | Immunohistochemical profile of breast carcinomas in correlation with histological gradeexperience of a tertiary care hospital in Andhra Pradesh | |
| Dolka et al. | Evaluation of canine mammary tumors using cytologic features, computerized cytomorphometry and immunocytochemistry |